||Registry of biomedical companies:
  [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [Z] 501 active entries
Fort Floor, Block No. C2, Plot No. 296, Janakpuri
Stock symbol: APTIN
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
A FALLOUT OF NASDAQ COMPANY IN INDIA- AceProbe has evolved with a team of Biotech professionals and operates in the niche area of genomics that enable our partners to efficiently design and perform experiments, monitor progress, receive and interpret results, and making the adoption of technology in a trivial manner. By partnering with AceProbe, scientists can rapidly discover complex connections between genetic profiles, disease risk and therapeutic response, with ease.
Our comprehensive Technology Platform and System offerings allow access to a multitude of clinical and research data, key analysis modules for both genotype and expression information, and database archiving and processing capabilities. Flexible platform and custom service features for a medium-density, ultra-high-throughput, customizable format make all its offerings unique with unmatched credentials and allows researchers to stratify patient populations prior to conducting clinical trials. Because it uniquely characterizes individuals' responses to specific medications, our partners :
Streamline the drug development process
Reduce development costs
Optimize dosage and increase safety
Increase the chances of success in clinical trials
Extend and Build ropbust, product life and intellectual property opportunities.
Last update of this entry: August 15, 2018